MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting (Q59307819)
Jump to navigation
Jump to search
scientific article published on 18 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting |
scientific article published on 18 February 2014 |
Statements
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting (English)
Shmuel Shoham
Jack D Sobel
Luis Ostrosky-Zeichner
Peter G Pappas
Jose Vazquez
Robert Betts
Michelle A Barron
Mindy Schuster
Marc A Judson
Sanjay G Revankar
Juan Pablo Caeiro
Julie E Mangino
David Mushatt
Roger Bedimo
Alison Freifeld
Minh Hong Nguyen
Carol A Kauffman
William E Dismukes
Jeanna Beth Deerman
18 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference